SG46623A1 - A process for purifying 1-[n-((s)-ethoxycarbonyl-3-phenylpropyl)-n-triflu oroacetyl]-l-lysyl-l-proline (ethylester of lisinopril(tra) - Google Patents
A process for purifying 1-[n-((s)-ethoxycarbonyl-3-phenylpropyl)-n-triflu oroacetyl]-l-lysyl-l-proline (ethylester of lisinopril(tra)Info
- Publication number
- SG46623A1 SG46623A1 SG1996006804A SG1996006804A SG46623A1 SG 46623 A1 SG46623 A1 SG 46623A1 SG 1996006804 A SG1996006804 A SG 1996006804A SG 1996006804 A SG1996006804 A SG 1996006804A SG 46623 A1 SG46623 A1 SG 46623A1
- Authority
- SG
- Singapore
- Prior art keywords
- lysyl
- phenylpropyl
- ethoxycarbonyl
- proline
- purifying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4331540A DE4331540A1 (de) | 1993-09-17 | 1993-09-17 | Verfahren zur Reinigung von 1-[N·2·-((S)-Ethoxycarbonyl)-3-phenylpropyl)-N·6·-trifluoracetyl]-L-lysyl-L-prolin (Lisinopril(Tfa)ethylester) |
| US08/616,885 US5616727A (en) | 1993-09-17 | 1996-03-18 | Process for purifying 1-[N2 -((S)-ethoxycarbonyl)-3-phenylpropyl)-N6 -trifluoroacetyl]-l-lysyl-l-proline (lisinopril (TFA) ethyl ester |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG46623A1 true SG46623A1 (en) | 1998-02-20 |
Family
ID=25929624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996006804A SG46623A1 (en) | 1993-09-17 | 1994-08-19 | A process for purifying 1-[n-((s)-ethoxycarbonyl-3-phenylpropyl)-n-triflu oroacetyl]-l-lysyl-l-proline (ethylester of lisinopril(tra) |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5616727A (ja) |
| EP (1) | EP0719279B1 (ja) |
| JP (1) | JP2752520B2 (ja) |
| AT (1) | ATE160355T1 (ja) |
| CZ (1) | CZ285157B6 (ja) |
| DE (2) | DE4331540A1 (ja) |
| DK (1) | DK0719279T3 (ja) |
| ES (1) | ES2111324T3 (ja) |
| GR (1) | GR3025570T3 (ja) |
| HU (1) | HU219596B (ja) |
| IL (1) | IL110969A (ja) |
| SG (1) | SG46623A1 (ja) |
| WO (1) | WO1995007928A1 (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1243594B1 (en) * | 1993-01-08 | 2004-05-12 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Process for crystallizing N2-((S)-1-ethoxycarbonyl-3-phenylpropyl)-N6-trifluoroacetyl-L-lysyl-L-proline |
| US5614609A (en) * | 1994-10-20 | 1997-03-25 | Carlos F. Ibanez | Serine threonine kinase receptor |
| US5962696A (en) * | 1997-06-23 | 1999-10-05 | Degussa Aktiengesellschaft | Process for the preparation of 1-(N 2-(S)-ethoxycarbonyl)--3 phenylpropyl-N6-trifluoracetyl))-L-lysyl-L-prolin (Lisinopril(Tfa) ethylester, LPE)) |
| US5907044A (en) * | 1997-07-30 | 1999-05-25 | Degussa Aktiengellschaft | Method of isolating 1- N2 -((S)-ethoxycarbonyl)-3-phenylpropyl)-N6 -trifluoroacetyl!-L-lysyl-L-proline (lisinopril (TFA) ethyl ester, LPE) |
| CZ292494B6 (cs) * | 1998-09-22 | 2003-10-15 | Kaneka Corporation | Způsob výroby N2-(1(S)-karboxy-3-fenylpropyl)-L-lysyl-L-prolinu |
| US6462174B1 (en) | 2001-06-25 | 2002-10-08 | Astrazeneca Ab | Amorphous compound |
| US6627760B1 (en) | 2001-06-25 | 2003-09-30 | Astrazeneca Ab | Amorphous compound |
| US6458769B1 (en) | 2001-06-25 | 2002-10-01 | Astrazeneca Ab | Amorphous compound |
| US7373857B2 (en) * | 2002-07-29 | 2008-05-20 | William Engineering Llc | Composite metal article and method of making |
| CN101985462A (zh) * | 2010-10-29 | 2011-03-16 | 浙江工业大学 | 一种赖诺普利酯的分离方法 |
| CN104045687B (zh) * | 2014-05-21 | 2016-08-24 | 丽珠医药集团股份有限公司 | 一种赖诺普利的提纯方法 |
| CN109422702B (zh) * | 2017-08-30 | 2023-04-18 | 上海科胜药物研发有限公司 | 赖诺普利中间体及其纯化方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01254651A (ja) * | 1988-04-04 | 1989-10-11 | Kanegafuchi Chem Ind Co Ltd | Ｎ↑２−（１−カルボキシ−３−フエニルプロピル）−ｌ−リジン誘導体及び該化合物を用いるリジノプリルの製造法 |
| DE4123248C2 (de) * | 1991-07-13 | 1996-03-07 | Degussa | Verfahren zur Herstellung von N-substituierten alpha-Aminosäuren und alpha-Aminosäure-Derivaten |
| EP1243594B1 (en) * | 1993-01-08 | 2004-05-12 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Process for crystallizing N2-((S)-1-ethoxycarbonyl-3-phenylpropyl)-N6-trifluoroacetyl-L-lysyl-L-proline |
-
1993
- 1993-09-17 DE DE4331540A patent/DE4331540A1/de not_active Ceased
-
1994
- 1994-08-19 JP JP7508932A patent/JP2752520B2/ja not_active Expired - Lifetime
- 1994-08-19 CZ CZ96799A patent/CZ285157B6/cs not_active IP Right Cessation
- 1994-08-19 AT AT94924885T patent/ATE160355T1/de not_active IP Right Cessation
- 1994-08-19 ES ES94924885T patent/ES2111324T3/es not_active Expired - Lifetime
- 1994-08-19 WO PCT/EP1994/002760 patent/WO1995007928A1/de active IP Right Grant
- 1994-08-19 SG SG1996006804A patent/SG46623A1/en unknown
- 1994-08-19 DE DE59404646T patent/DE59404646D1/de not_active Expired - Lifetime
- 1994-08-19 HU HU9600675A patent/HU219596B/hu not_active IP Right Cessation
- 1994-08-19 EP EP94924885A patent/EP0719279B1/de not_active Expired - Lifetime
- 1994-08-19 DK DK94924885T patent/DK0719279T3/da active
- 1994-09-14 IL IL11096994A patent/IL110969A/en not_active IP Right Cessation
-
1996
- 1996-03-18 US US08/616,885 patent/US5616727A/en not_active Expired - Lifetime
-
1997
- 1997-12-02 GR GR970403220T patent/GR3025570T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5616727A (en) | 1997-04-01 |
| JPH09501697A (ja) | 1997-02-18 |
| CZ285157B6 (cs) | 1999-05-12 |
| IL110969A0 (en) | 1994-11-28 |
| IL110969A (en) | 1998-07-15 |
| CZ79996A3 (en) | 1996-06-12 |
| ATE160355T1 (de) | 1997-12-15 |
| HU219596B (hu) | 2001-05-28 |
| DE4331540A1 (de) | 1995-03-23 |
| ES2111324T3 (es) | 1998-03-01 |
| GR3025570T3 (en) | 1998-03-31 |
| EP0719279A1 (de) | 1996-07-03 |
| WO1995007928A1 (de) | 1995-03-23 |
| DE59404646D1 (de) | 1998-01-02 |
| DK0719279T3 (da) | 1998-07-27 |
| EP0719279B1 (de) | 1997-11-19 |
| HU9600675D0 (en) | 1996-05-28 |
| JP2752520B2 (ja) | 1998-05-18 |
| HUT75536A (en) | 1997-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG46623A1 (en) | A process for purifying 1-[n-((s)-ethoxycarbonyl-3-phenylpropyl)-n-triflu oroacetyl]-l-lysyl-l-proline (ethylester of lisinopril(tra) | |
| DE69739035D1 (de) | Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen | |
| ATE295346T1 (de) | N-(aryl/heteroarylacetyl)aminosäureester, diese enthaltende pharmazeutische zusammensetzungen und methoden zur inhibierung der beta- amyloidfreisetzung und/oder deren synthese unter verwendung dieser verbindungen | |
| EP0528312A3 (en) | Cyclic peptides and use thereof | |
| WO2002048183A3 (en) | Compositions of peptide crystals | |
| DE69635271D1 (de) | Verfahren zu behandlung von amyloidosis | |
| HUP9901209A3 (en) | Opioid-like peptide compounds, process for producing them and pharmaceutical compositions containing them | |
| DK0910571T3 (da) | Hidtil ukendte antiangiogene peptider, polynucleotider, der koder for samme, samt fremgangsmåder til inhibering af angiogenese | |
| EE9400326A (et) | Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid | |
| HUT44042A (en) | Process for preparing renin inhibitor peptides, amino acid and aminoaldehyde derivatives, as well as pharmaceuticals comprising renin inhibitor peptides | |
| AU579593B2 (en) | Novel peptides which are active on the central nervous system and have an action on the cholinergic system | |
| KR970706305A (ko) | 성장 호르몬의 분비를 촉진할 수 있는 d-2-알킬트립토판을 함유하는 폴리펩티드 화합물(polypeptide compounds containing d-2-alkyltrytophan capable of promoting the release of growth hormone) | |
| MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
| HU9601977D0 (en) | Mixtures containing amino acides and dipeptides, process for producing the dipeptides, and pharmaceutical compositions containing these mixtures and/or dipeptides | |
| AU3494093A (en) | S-lipophilic aliphatic carbonyl {n-mercaptoacyl-(amino acid or peptide)} compounds as antihypertensive agents | |
| DE69332738D1 (de) | Verfahren zur kristallisation von n2-((s)-1-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoracetyl-l-lysyl-l-prolin | |
| AU5142000A (en) | A process for isolating and purifying viruses, soluble proteins and peptides from plant sources | |
| DE69934683D1 (de) | Verfahren zur reduzierung von echinocandin-peptiden zu deren c4-monodeoxyhomotyrosin analoga | |
| AU4459400A (en) | A method for the purification of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester | |
| DE69731795D1 (de) | System zur Korrektur von Bandverfärbung | |
| EP0730898A3 (en) | Separation of volatile organic components by membrane using a counter-current purge gas | |
| ATE46173T1 (de) | Pharmakologisch aktive peptide. | |
| IN190885B (ja) | ||
| DE69420044D1 (de) | Blutregulierende peptide | |
| IT1203600B (it) | Metodo per preparare il (d-trp6)-lhrh |